Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Capital Medical University
With
This multicenter, randomized, parallel-group, sham-controlled trial aims to evaluate the efficacy and safety of acute intermittent hypoxia (aIH) in patients with depressive disorders and to investigate its potential mechanisms of action. A total of 156 participants will be recruited from one lead center (Beijing Anding Hospital) and three participating centers. Participants will be randomly assigned in a 1:1 ratio to aIH or sham intervention using block randomization stratified by study center. Both groups will complete 10 treatment sessions over 2 weeks, followed by a 6-week follow-up period. The aIH intervention will consist of alternating periods of hypoxia and normoxia. An individualized oxygen concentration for hypoxic exposure will be established before treatment based on tolerability and will remain fixed throughout the 10-session treatment course. The sham intervention will be administered under normoxic conditions. Clinical assessments will be conducted at baseline and at weeks 1, 2, and 8. The primary outcome is the between-group difference in change in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score from baseline to week 2 (After 10 Treatment Sessions). Exploratory assessments will include hypoxia tolerance testing and functional near-infrared spectroscopy (fNIRS). A subset of participants will undergo additional neurophysiological assessments, brain imaging, magnetoencephalography (MEG), and peripheral blood sampling at selected time points, including baseline, the end of the intervention, and the end of follow-up, to explore potential neurobiological mechanisms underlying the effects of aIH. One interim analysis of efficacy and safety is planned after approximately half of the participants have completed the primary endpoint assessment. An independent Data Monitoring Committee will review unblinded interim data according to prespecified procedures.
Age
18–45
Sex
ALL
Healthy volunteers
Not accepted
